For the quarter ended June 30, 2025, revenue surged 317% to $2.6 million, compared with $0.6 million a year earlier. Gross ...

Bitfarmsshares are trading lower on Tuesday as weakness in the cryptocurrency market drove down valuations of crypto-linked ...

Although Alphabet was caught in Tuesday's tech selloff, there's a statistical case for buying into a possible sentiment ...

William Blair starts Thermo Fisher with an Outperform rating, citing strong M&A, solid balance sheet, and 22% upside ...

Shares of Netflix are trading lower Tuesday afternoon. The stock may be reacting to news that Stranger Things creators, the ...

The Firm Takes Shape In 1980, Smith founded Donald Smith & Co. with a simple but powerful philosophy: invest in stocks ...

Howard Marks dissects market madness, separating price from value, and warns investors: fundamentals are fading while ...

Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-off ...

Trump's flip-flopping on Intel highlights the impact of politics on investor sentiment. New leadership, government investment ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $5.56, along ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.65, with a ...

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.